Niagen Bioscience (NAGE) Interest Coverage Ratio (2010 - 2022)
Niagen Bioscience (NAGE) reported Interest Coverage Ratio of 613.0 for Q3 2022, down 4.0% year-over-year from 638.57 in Q3 2021, and up 4.02% quarter-over-quarter from 638.7 in Q2 2022.
Niagen Bioscience (NAGE) Interest Coverage Ratio (2010 - 2022) Analysis & Trends
Niagen Bioscience (NAGE) has 13 years of Interest Coverage Ratio data on file, last reported at 613.0 in Q3 2022.
- Interest Coverage Ratio for Q3 2022 came in at 613.0, down 4.0% year-over-year; the trailing twelve-month figure through Jun 2023 was 1758.6 (down 161.22% YoY), and the FY2021 annual result was 492.24, down 76.03% from the prior year.
- Interest Coverage Ratio advanced to 613.0 in Q3 2022 per NAGE's latest filing, from 638.7 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 12.49 in Q2 2019 and troughed at 966.5 in Q1 2022.
- A 5-year average of 420.38 and a median of 387.47 in 2021 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2018 and 2019: Interest Coverage Ratio plunged 1253.27% in 2018, then soared 97.7% in 2019.
- A 5-year view of Interest Coverage Ratio shows it stood at 955.11 in 2018, then surged by 97.7% to 21.94 in 2019, then plunged by 1632.57% to 380.06 in 2020, then slumped by 55.41% to 590.67 in 2021, then decreased by 3.78% to 613.0 in 2022.
- Business Quant data shows NAGE's Interest Coverage Ratio at 613.0 in Q3 2022, 638.7 in Q2 2022, and 966.5 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -613.00 |
| Jun 30, 2022 | -638.70 |
| Mar 31, 2022 | -966.50 |
| Dec 31, 2021 | -590.67 |
| Sep 30, 2021 | -589.40 |
| Jun 30, 2021 | -462.83 |
| Mar 31, 2021 | -387.47 |
| Dec 31, 2020 | -380.06 |
| Sep 30, 2020 | -220.84 |
| Jun 30, 2020 | -153.63 |
| Sep 30, 2019 | -21.94 |
| Jun 30, 2019 | -12.49 |
| Sep 30, 2018 | -955.11 |
| Jun 30, 2018 | -122.11 |
| Mar 31, 2018 | -190.89 |
| Dec 30, 2017 | -199.50 |
| Sep 30, 2017 | -70.58 |
| Jul 1, 2017 | -73.61 |
| Apr 1, 2017 | -63.32 |
| Dec 31, 2016 | -118.30 |